QuidelOrtho to Report Second Quarter 2022 Financial Results on August 4, 2022
July 18, 2022 16:05 ET
|
QuidelOrtho Corporation
SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a leading in vitro diagnostics company, today announced it will report financial results for its...
Quidel and Ortho Announce Expected Closing of Ortho Transaction
May 26, 2022 12:24 ET
|
Ortho-Clinical Diagnostics, Inc; Quidel Corporation
SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic...
Ortho Clinical Diagnostics Shareholders Approve Quidel Transaction
May 16, 2022 16:45 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho” or the “Company”), one of the world’s largest pure-play in vitro diagnostics (IVD)...
Ortho Clinical Diagnostics Reports First Quarter 2022 Results
May 04, 2022 16:05 ET
|
Ortho-Clinical Diagnostics, Inc
Highlights • Core revenue declined (0.9%) to $495.0 million, and grew 0.6% in constant currency and 4.2% excluding CoV-2 assay sales, which was a 4% headwind • Growth, excluding CoV-2 assay sales,...
Ortho Clinical Diagnostics Recognized with Fifth Prestigious Edison Award for Highly Accurate COVID-19 Solution
April 26, 2022 08:59 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, has been recognized with a...
Ortho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022
April 20, 2022 16:14 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it will...
Ortho Clinical Diagnostics Wins Bronze Stevie® Award for Customer Service and Support
March 09, 2022 08:55 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., March 09, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, has been awarded a Bronze 2022...
Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2021 Results
February 16, 2022 16:05 ET
|
Ortho-Clinical Diagnostics, Inc
Highlights • Fourth quarter Core revenue grew 3.5% to $518.9 million, or 4.3% in constant currency and 8.0% excluding CoV-2 assay sales • Fiscal year Core revenue grew 16.1% to $2.01 billion, or...
Ortho Clinical Diagnostics Holdings Plc (“Ortho”): Notice of UK Court Scheme Directions Hearing
January 24, 2022 08:00 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Further to the joint announcement by Ortho and Quidel Corporation (“Quidel”) on December 23, 2021 of the signing of a definitive business combination...
Ortho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2021
January 06, 2022 16:50 ET
|
Ortho-Clinical Diagnostics, Inc
Expects 4Q Reported and Constant Currency Core Revenue Growth of ~4%Fiscal Year Reported and Constant Currency Core Revenue Growth of ~16% and ~15%, respectively RARITAN, N.J., Jan. 06, 2022 ...